Testing Xeomin injections to prevent chronic migraine
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This trial tests if Xeomin (a botulinum toxin injection) can help prevent chronic migraine. If you have frequent migraine headaches, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had chronic migraine (with or without aura) for at least 12 months and can tell migraine from other headaches.
- Your migraines started before age 50.
- In the 3 months before screening, you had at least 15 headache days per month and at least 8 migraine days per month.
- During the last 28 days of screening, you had at least 15 headache days and at least 8 migraine days.
- You are not taking more than one prescribed migraine prevention drug.
- If you previously took anti-CGRP injections (like Aimovig or Emgality), you must have stopped at least 5 months ago.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study compares two headache injections—Botox and Xeomin—for people with chronic migraine. It may help find out which option works better to reduce frequent, long-lasting migraine days.
This study looks at how preventive treatments (botulinum toxin type A or anti-CGRP antibodies) affect thinking, memory, and quality of life in adults with hard-to-treat migraines. It aims to see if these treatments help more than just reducing headache days.
This trial looks at the chemical changes in the blood of people with migraine. It aims to better understand the disease and may help find new treatments. You may qualify if you have episodic or chronic migraine and have not tried CGRP-targeting drugs.
This trial tests whether the cholesterol drug atorvastatin can reduce the number of migraine days in people with chronic migraine (15 or more headache days per month, including at least 8 migraine days). If you have frequent migraines and haven't tried statins before, this study may offer a new preventive option.
This trial tests if Xeomin injections can help prevent episodic migraines in people who have 6 to 14 migraine days per month. It's for those under 50 when their migraines started and who can tell migraine from other headaches.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
Hear when a new Chronic Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.